1-(4-(2-Hydroxy-3-(quinolin-5-yloxy)propyl)piperazin-1-yl)-2,2-diphenylethanone, 97%

Name: 1-(4-(2-Hydroxy-3-(quinolin-5-yloxy)propyl)piperazin-1-yl)-2,2-diphenylethanone, 97% | 129716-58-1
Brand: J&K Chemical
SKU: JK9255884_1_G
Price: 1526.31 USD
Availability: OutOfStock

Cat. No JK9255884_1_G

Vendor: J&K Chemical

Product Information

Product Name

1-(4-(2-Hydroxy-3-(quinolin-5-yloxy)propyl)piperazin-1-yl)-2,2-diphenylethanone, 97%

Brand Name

J&K

Product Number

9255884

CAS

129716-58-1

Certificate of Analysis (COA)

COA not found

General Information

PubChem CID

213040

IUPAC Name

1-4-(2-hydroxy-3-quinolin-5-yloxypropyl)piperazin-1-yl-2,2-diphenylethanone

InChI Key

KLWUUPVJTLHYIM-UHFFFAOYSA-N

SMILES

C1CN(CCN1CC(COC2=CC=CC3=C2C=CC=N3)O)C(=O)C(C4=CC=CC=C4)C5=CC=CC=C5

References Data Source From Pubchem

BI-2865, a pan-KRAS inhibitor, reverses the P-glycoprotein induced multidrug resistance in vitro and in vivo

Publication Name: Cell communication and signaling : CCS

Publication Date: 2024-06-13

DOI: 10.1186/s12964-024-01698-4

Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies

Publication Name: Medical oncology (Northwood, London, England)

Publication Date: 2024-04-09

DOI: 10.1007/s12032-024-02347-z

Modulators of Candida albicans Membrane Drug Transporters: A Lucrative Portfolio for the Development of Effective Antifungals

Publication Name: Molecular Biotechnology

Publication Date: 2024-01-11

DOI: 10.1007/s12033-023-01017-1

TTD: Therapeutic Target Database describing target druggability information

Publication Name: Nucleic Acids Research

Publication Date: 2023-09-15

DOI: 10.1093/nar/gkad751

BLM overexpression as a predictive biomarker for CHK1 inhibitor response in PARP inhibitor–resistant BRCA -mutant ovarian cancer

Publication Name: Science Translational Medicine

Publication Date: 2023-06-21

DOI: 10.1126/scitranslmed.add7872

1-(4-(2-Hydroxy-3-(quinolin-5-yloxy)propyl)piperazin-1-yl)-2,2-diphenylethanone, 97%

Product Information

General Information

References Data Source From Pubchem

BI-2865, a pan-KRAS inhibitor, reverses the P-glycoprotein induced multidrug resistance in vitro and in vivo

Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies

Modulators of Candida albicans Membrane Drug Transporters: A Lucrative Portfolio for the Development of Effective Antifungals

TTD: Therapeutic Target Database describing target druggability information

BLM overexpression as a predictive biomarker for CHK1 inhibitor response in PARP inhibitor–resistant BRCA -mutant ovarian cancer